Nuclear receptor raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-01-28. Anything still debated is marked as such rather than presented as settled.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
| Property | Value | Notes |
|---|---|---|
| Solubility | Soluble in dimethyl sulfoxide and some organic solvents; practically insoluble in water | Solvent choice affects laboratory handling |
| Typical storage | -20 °C, desiccated, protected from light | Common condition for research samples |
| Analytical method | Liquid chromatography–tandem mass spectrometry (LC-MS/MS) | Used for identification and quantification in biological or product samples |
| Common synonyms | GW501516, GW-501516, GSK-516, Endurobol | Names found in research and anti-doping literature |
| Regulatory status | Unapproved therapeutic; prohibited in competitive sport | Status can vary by country and context |
GW501516 acts as an agonist at the peroxisome proliferator-activated receptor delta, a nuclear receptor that regulates gene expression. Activation shifts transcription toward genes involved in fatty acid uptake, oxidation, and energy expenditure. The compound does not bind the androgen receptor and therefore differs from anabolic steroids and SARMs. In rodent models, this metabolic shift has been linked to increased running endurance and reduced fat accumulation. The exact downstream pathways in humans remain incompletely characterized.
Early clinical research explored GW501516 for lipid disorders, obesity, and diabetes. Some short-term human studies reported changes in HDL cholesterol, LDL cholesterol, and triglycerides. The development program was discontinued after rodent studies showed dose-dependent tumor formation in multiple tissues, including liver, bladder, stomach, and skin. These findings raised concerns about long-term cancer risk in humans. Because human exposure data are limited, the clinical significance of the rodent tumors remains uncertain.
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
The shape of the ends of the bones — Some joints normally have a large range of movement, such as the shoulder and hip. Both are ball-and-socket joints. The joint ends of bones finish their growth last, so children tend to have more flexible joints than adults; children may "grow out of" hypermobility as their bone ends fully develop. A shallow socket will lead to a relatively large range of movement. If the hip socket is particularly shallow, then the hip may dislocate easily. Ligament problems— Ligaments are made of several types of protein fiber, including elastin and collagen. Gymnasts and athletes can voluntarily acquire hypermobility in some joints by stretching healthy ligaments over time. However, weak or abnormally long ligaments can cause unstable hypermobile joints. Protein deficiencies may weaken ligaments. Some hormones may alter the structure of collagen proteins. For example, in late pregnancy, relaxin allows the ligaments of the pelvis to lengthen so the head of the baby can pass. Muscle tone—Opposing sets of muscles are attached to bones to move joints in various directions. The tone of muscles—a mild basic level of contraction that protects joints and organs—is controlled by the nervous system. Neuromuscular problems can cause loss of muscle tone, increasing the range of movement possible and removing the muscles' protection of the joint. Lack of exercise also weakens the muscles that support and anchor highly flexible joints such as the shoulder, hip, wrist, and ankle.
=== As a supplement === A series of studies showed that a combination of betaine and glycocyamine improves the symptoms of patients with chronic illness, including heart disease, without toxicity. Betaine can provide a methyl group to glycocyamine, via methionine, for the formation of creatine. In overall, such treatment led to less fatigue, greater strength and endurance, and an improved sense of well-being. The patients with cardiac decompensation (arteriosclerosis or rheumatic disease) and congestive heart failure had improved cardiac function. The patients gained weight (improved nitrogen balance) and saw lessened symptoms of arthritis and asthma and increased libido, and those people suffering from hypertension experienced transient reduced blood pressure. Also the studies shows the increase of glucose tolerance in both diabetic subjects and subjects without diabetes.
Depletion of PPARG in mice results in embryonic lethality at E10.5, due to the vascular anomalies in placenta, with no permeation of fetal blood vessels and dilation and rupture of maternal blood sinuses. The expression of PPARG can be detected in mouse placenta as early as E8.5 and through the remainder of gestation; in the human placenta, PPARG is mainly located in the primary trophoblast cell. PPARG is required for epithelial differentiation of trophoblast tissue in mice, which is critical for proper placenta vascularization. PPARG agonists inhibit extravillous cytotrophoblast invasion. PPARG is also required for the accumulation of lipid droplets by the placenta in mice.
Another interpretation, using density functional theory calculation, goes as follows: C=C with defects such as functional groups and pentagons (283.6 eV), C=C (non-oxygenated ring contexts) (284.3 eV), sp3C-H in the basal plane and C=C with functional groups (285.0 eV), C=O and C=C with functional groups, C-O (286.5 eV), and O-C=O (288.3 eV). Graphite oxide is hydrophilic and easily hydrated when exposed to water vapor or immersed in liquid water, resulting in a distinct increase of the inter-planar distance (up to 1.2 nm in saturated state). Additional water is also incorporated into the interlayer space due to high pressure induced effects. The maximal hydration state of graphite oxide in liquid water corresponds to insertion of 2-3 water monolayers. Cooling the graphite oxide/H2O samples results in "pseudo-negative thermal expansion" and cooling below the freezing point of water results in de-insertion of one water monolayer and lattice contraction. Complete removal of water from the structure seems difficult since heating at 60–80 °C results in partial decomposition and degradation of the material.
Sources: en.wikipedia.org
== Additional functions == The ILEA had its own schools broadcasting service, the Educational Television Service, based in the former Tennyson Secondary School, Thackeray Road, SW8. The television centre had two functional television studios, a training studio, a master control and sound and vision mixing suites. At one stage this was believed to be the largest closed-circuit television system in the world. The first transmission took place on 16 September 1969 and the Television Service ran until 1977. When the Post Office, whose cabling was used for the distribution, wanted to withdraw from its contract in the late 1970s, the programming was transferred to VHS tapes and the CCTV network closed down. The Cockpit Theatre, Marylebone (also known at the Cockpit Youth and Arts Centre), in Gateforth Street, London, NW8, was built for the ILEA on the edge of the Lisson Green estate in 1969–70. It was designed as a Theatre in the round by Edward Mendelsohn. The ILEA created the first Theatre in Education company to be entirely housed within a local education authority. It employed seven actor-teachers and a stage manager and focused its work on secondary schools and Further Education. As well as traditional T.I.E. the Cockpit team used the approach to develop shows analysing set texts. When ILEA was abolished in 1990, ownership of the theatre transferred to the London Borough of Westminster. The ILEA had a planetarium, based at Wandsworth School. It was opened by the Astronomer Royal Sir Richard Woolley on 19 May 1966.
July 12: Law concerning freedom of higher education (for boys). July 24: "Women of ill repute" are kept away from the gendarmerie. 1879 August 9: Law establishing primary teacher training colleges: each department is required to have one, with a version for training male teachers and another for training female teachers—destined for communal schools. December 5: Decree organizing the General Inspectorate of Administrative Services of the Ministry of the Interior; among the planned measures is the creation of a post for a female general inspector—her salary is lower than that of her male counterparts; this general inspector is particularly in charge of inspecting girls' penal institutions and women's establishments. 1880
Between 12 and 14 June, Datafolha interviewed another 2,010 people in 112 Brazilian municipalities, and the Lula government received a good or excellent rating from 37% of respondents, regular from 33%, and bad or terrible from 27%. Three percent of respondents did not express an opinion. According to the survey, Lula's third term maintained a good "balance" of approval and regular ratings over five months, surpassing the ratings of the previous governments of Collor, Temer and Bolsonaro, but still being surpassed by the ratings of the first-term governments of FHC and Dilma. Between 15 and 18 June, the Genial/Quaest institute interviewed 2,029 voters over the age of 16, and the survey showed an increase in the rating from 51% to 56% again compared with the survey released in April of that year. That percentage represents those who said that Lula governs the country well, and the decrease from 42% to 40% represents those who said that Lula governs the country badly. From the end of June to the beginning of July, Lula's third government was measured by the newspaper PoderData, with 2,500 respondents from 262 municipalities across the country, ending the first half of the year with a "balance" in approval. Fifty-one percent of respondents rated Lula's administration positively, while 43% disapproved of the administration and 6% did not know how to rate it. The newspaper also asked respondents how they rated Lula governing the country, and in 3 months the percentage for good governance rose by two points (from 39% to 41%).
Sources: en.wikipedia.org
It binds and activates PPARδ, a nuclear receptor that influences gene expression related to fatty acid metabolism and energy balance. This mechanism has been studied mainly in animals and cell models, not established as a safe human therapy.
No. It is not an anabolic-androgenic steroid; it is a synthetic PPARδ agonist. Because it is banned in sport, it is sometimes grouped with doping agents even though its chemical class differs from steroids.
Human data are limited and development was discontinued, so major effects and long-term risks are not well characterized. Some early studies examined metabolic markers, but they do not provide a basis for unsupervised use.
Cardarine is a common name for GW501516, a synthetic PPARδ agonist. It is not a steroid or a selective androgen receptor modulator. It was developed and studied as a research compound for metabolic pathways.